Instil Bio, Inc. (TIL)
$5.95-3.72%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $40M
- Beta
- 1.94
- P/E (TTM)
- -1.33
- Short % float
- 4.39%
- Days to cover
- 9.3
- SI change
- -1.8%
- 1W
- -13.77%
- 1M
- -17.48%
- vs SPY 1W
- -13.63%
- vs SPY 1M
- -19.98%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on TIL?
- LOPJLB’s latest quantitative signal on Instil Bio, Inc. (TIL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TIL in?
- Instil Bio, Inc. (TIL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Instil Bio, Inc. (TIL) do?
- Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.